Suppression of tumor growth in human hepatocellular carcinoma by systemic delivery of SNALP-formulated siRNA for downregulation of HDAC2

被引:0
|
作者
Lee, Yun-Han
Song, Ho-Taek
Judge, Adam
Andersen, Jesper
Ishikawa, Tsuyoshi
Avital, Itzhak
Durkin, Marian
Raggi, Chiara
Ton, Anita
Conner, Elizabeth
MacLachlan, Ian
Factor, Valentina
Thorgeirsson, Snorri
机构
[1] NCI, Bethesda, MD 20892 USA
[2] Yonsei Univ, Seoul 120749, South Korea
[3] Protiva Biotherapeut Inc, Burnaby, BC, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2857
引用
收藏
页数:1
相关论文
共 43 条
  • [31] Suppression of tumor growth by a M2b macrophage reverter in humanized murine chimeras created with peripheral blood monocytes of patients with advanced stage hepatocellular carcinoma
    Tsuchimoto, Yusuke
    Asai, Akira
    Ohama, Hideko
    Yokohama, Keisuke
    Nakamura, Ken
    Fukunishi, Shinya
    Tsuda, Yasuhiro
    Higuchi, Kazuhide
    Kobayashi, Makiko
    Suzuki, Fujio
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [32] Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells
    Gao, Juan
    Dong, Yongqiang
    Zhang, Bicheng
    Xiong, Yimin
    Xu, Weitian
    Cheng, Yi
    Dai, Meng
    Yu, Zhao
    Xu, Hualin
    Zheng, Guorong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (05) : 1773 - 1781
  • [33] Inhibition of Tumor Growth of Human Hepatocellular Carcinoma HepG2 Cells in a Nude Mouse Xenograft Model by the Total Flavonoids from Arachniodes exilis
    Li, Huimin
    Jiang, Dengzhao
    Zhang, Lei
    Wu, Jiazhong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [34] Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice
    Wang, Guan-Yu
    Lv, Qing-Hua
    Dong, Qi
    Xu, Rong-Zhen
    Dong, Qing-Hua
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2009, 11 (03) : 219 - 228
  • [35] Anti-endostatin monoclonal antibody inhibits antiangiogenic activity of endogenous endostatin secreted from human hepatocellular carcinoma xenografted in nude mice and promotes growth of the tumor by suppression of apoptosis.
    Tsuboi, S
    Manabe, K
    Ohmori, H
    Tomono, Y
    Naito, I
    Miyazaki, M
    Ninomiya, Y
    Nouso, K
    Nakatsukasa, H
    Higashi, T
    Tsuji, T
    HEPATOLOGY, 2001, 34 (04) : 387A - 387A
  • [36] Evaluation of apoptotic marker Bcl2, CD4+, human hepatocyte growth factor and metalloproteinase-9 as tumor markers for patients with hepatocellular carcinoma
    Youness E.R.
    El Nemr M.
    Oraby F.S.
    Ahmed N.M.
    Moghni M.A.
    Aly H.F.
    Ahmed H.H.
    Indian Journal of Clinical Biochemistry, 2014, 29 (3) : 351 - 356
  • [37] Stable ASCT2 and LAT1 Suppression in Human Hepatocellular Carcinoma Cells Fails to Measurably Affect Proliferation, Anchorage-independent Growth and mTORC1 Signaling
    Bothwell, Paige
    Wittke, Evan
    Papa, Afreen
    Mitzelfelt, Jordon
    Howard, Zachary
    Kron, Clare
    Bode, Barrie
    FASEB JOURNAL, 2015, 29
  • [38] Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma
    Kim, Jeong Kyu
    Jung, Kwang Hwa
    Noh, Ji Heon
    Eun, Jung Woo
    Bae, Hyun Jin
    Xie, Hong Jian
    Ahn, Young Min
    Ryu, Jae Chun
    Park, Won Sang
    Lee, Jung Young
    Nam, Suk Woo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (06) : 1257 - 1264
  • [39] LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis
    Huang, Yuqi
    Xiang, Bo
    Liu, Yuanhua
    Wang, Yu
    Kan, Heping
    CANCER LETTERS, 2018, 437 : 56 - 66
  • [40] Zanthoxylum avicennae extracts induce cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and block tumor growth in xenografted nude mice
    Tran Duc Dung
    Chang, Hsien-Cheh
    Chen, Chung-Yu
    Peng, Wen-Huang
    Tsai, Chang-Hai
    Tsai, Fuu-Jen
    Kuo, Wei-Wen
    Chen, Li-Mien
    Huang, Chih-Yang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (06) : 927 - 936